Validity of "Sepsis-3" criteria in identifying patients with community-onset sepsis in Internal Medicine wards; a prospective, multicenter study.


Journal

European journal of internal medicine
ISSN: 1879-0828
Titre abrégé: Eur J Intern Med
Pays: Netherlands
ID NLM: 9003220

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 03 10 2020
revised: 10 12 2020
accepted: 11 12 2020
pubmed: 17 1 2021
medline: 24 4 2021
entrez: 16 1 2021
Statut: ppublish

Résumé

Few data are available on the validity of "Sepsis-3" criteria in identifying patients with sepsis in internal medicine wards (IMWs). Real-life data about this topic and on the prevalence of sepsis in IMWs could be useful for improving hospital organization. To assess the validity of "Sepsis-3" criteria in identifying patients with community-onset sepsis in IMWs. Secondary objectives: to evaluate the prevalence of these patients in IMWs and to compare "Sepsis-3" and "Sepsis-1" criteria. Multicenter, prospective, observational, cohort study, carried out in 22 IMWs of Tuscany (Italy). All patients admitted to each of the study centers over a period of 21-31 days were evaluated within 48 hours; those with clinical signs of infection were enrolled. The main outcome was in-hospital mortality. 2,839 patients were evaluated and 938 (33%) met the inclusion criteria. Patients with sepsis diagnosed according to "Sepsis-3" were 522, representing 55.6% of patients with infection and 18.4% of all patients hospitalized; they were older than those without sepsis (79.4±12.5 vs 74.6±15.2 years, p<0.001). In-hospital mortality was significantly higher in patients with sepsis compared to others (13.8% vs 4.6%; p<0.001). "Sepsis-3" criteria showed greater predictive validity for in-hospital mortality than "Sepsis-1" criteria (AUROC=0.71; 95%CI, 0.66-0.77 vs 0.60; 95%CI 0.54-0.66; p=0.0038). "Sepsis-3" criteria are able to identify patients with community-onset sepsis in IMWs, whose prevalence and in-hospital mortality are remarkably high. Medical departments should adapt their organization to the needs for care of these complex patients.

Sections du résumé

BACKGROUND BACKGROUND
Few data are available on the validity of "Sepsis-3" criteria in identifying patients with sepsis in internal medicine wards (IMWs). Real-life data about this topic and on the prevalence of sepsis in IMWs could be useful for improving hospital organization.
OBJECTIVES OBJECTIVE
To assess the validity of "Sepsis-3" criteria in identifying patients with community-onset sepsis in IMWs. Secondary objectives: to evaluate the prevalence of these patients in IMWs and to compare "Sepsis-3" and "Sepsis-1" criteria.
METHODS METHODS
Multicenter, prospective, observational, cohort study, carried out in 22 IMWs of Tuscany (Italy). All patients admitted to each of the study centers over a period of 21-31 days were evaluated within 48 hours; those with clinical signs of infection were enrolled. The main outcome was in-hospital mortality.
RESULTS RESULTS
2,839 patients were evaluated and 938 (33%) met the inclusion criteria. Patients with sepsis diagnosed according to "Sepsis-3" were 522, representing 55.6% of patients with infection and 18.4% of all patients hospitalized; they were older than those without sepsis (79.4±12.5 vs 74.6±15.2 years, p<0.001). In-hospital mortality was significantly higher in patients with sepsis compared to others (13.8% vs 4.6%; p<0.001). "Sepsis-3" criteria showed greater predictive validity for in-hospital mortality than "Sepsis-1" criteria (AUROC=0.71; 95%CI, 0.66-0.77 vs 0.60; 95%CI 0.54-0.66; p=0.0038).
CONCLUSIONS CONCLUSIONS
"Sepsis-3" criteria are able to identify patients with community-onset sepsis in IMWs, whose prevalence and in-hospital mortality are remarkably high. Medical departments should adapt their organization to the needs for care of these complex patients.

Identifiants

pubmed: 33451890
pii: S0953-6205(20)30477-5
doi: 10.1016/j.ejim.2020.12.025
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-97

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Alberto Fortini (A)

Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143 Firenze, Italy. Electronic address: xfortini@gmail.com.

Antonio Faraone (A)

Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143 Firenze, Italy.

Simone Meini (S)

Internal Medicine, Santa Maria Annunziata Hospital, Via Antella 58, 50012 Bagno a Ripol (Firenze), Italy; Internal Medicine, Felice Lotti Hospital, Via Roma, 147, 56025 Pontedera (Pisa), Italy.

Michael Bettucchi (M)

Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143 Firenze, Italy.

Benedetta Longo (B)

Internal Medicine, Felice Lotti Hospital, Via Roma, 147, 56025 Pontedera (Pisa), Italy.

Beatrice Valoriani (B)

Internal Medicine, Valdichiana Hospital, Località Nottola, 53045 Montepulciano (Siena), Italy.

Silvia Forni (S)

Regional Health Agency of Tuscany, Via Pietro Dazzi, 1, 50141 Firenze, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH